Oligomerization is required for HIV-1 Nef-induced activation of the Src family protein-tyrosine kinase, Hck

Biochemistry

Volumn 43, Issue 50, 2004, Pages 15775-15784

  Ye, Huihui ^a   Choi, Hyun Jung ^a   Poe, Jerrod ^a   Smithgall, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; BINDING ENERGY; CELLS; DISEASE CONTROL; HORMONES; PROTEINS;

HIV TARGET CELLS; MACROPHAGES; OLIGOMERIZATION; PLASMA MEMBRANES;

OLIGOMERS;

4 HYDROXYTAMOXIFEN; ESTROGEN RECEPTOR; HEMATOPOIETIC CELL KINASE; NEF PROTEIN;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; IN VIVO STUDY; MEMBRANE BINDING; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL MEMBRANE; CELLS, CULTURED; DIMERIZATION; ENZYME ACTIVATION; FIBROBLASTS; GENE PRODUCTS, NEF; GREEN FLUORESCENT PROTEINS; HIV-1; IMMUNOPRECIPITATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-HCK; RATS; RECEPTORS, ESTROGEN; SRC-FAMILY KINASES; TAMOXIFEN;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 10844282788     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi048712f     Document Type: Article

References (54)

1. Herna, R. G., and Saksela, K. (2000) Interactions of HIV-1 NEF with cellular signal transducing proteins, Front Biosci. 5, D268-D283.
2. Geyer, M., Fackler, O. T., and Peterlin, B. M. (2001) Structure-function relationships in HIV-1 Nef, EMBO Rep. 2, 580-585.
3. Arold, S. T., and Baur, A. S. (2001) Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein, Trends Biochem. Sci. 26, 356-363.
4. Kestler, H., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., and Desrosiers, R. C. (1991) Importance of the nef gene for maintenance of high viral loads and for development of AIDS, Cell 65, 651-662.
5. Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L., and Desrosiers, R. C. (1995) Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection, N. Engl. J. Med. 332, 228-232.
6. Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D. J., McPhee, D. A., Greenway, A. L., Ellett, A., Chatfield, C., Lawson, V. A., Crowe, S., Maerz, A., Sonza, S., Learmont, J., Sullivan, J. S., Cunningham, A., Dwyer, D., Dowton, D., and Mills, J. (1995) Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients, Science 270, 988-991.
7. Hanna, Z., Kay, D. G., Rebai, N., Guimond, A., Jothy, S., and Jolicoeur, P. (1998) Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice, Cell 95, 163-175.
8. Blagoveshchenskaya, A. D., Thomas, L., Feliciangeli, S. F., Hung, C. H., and Thomas, G. (2002) HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway, Cell 111, 853-866.
9. Piguet, V., Gu, F., Foti, M., Demaurex, N., Gruenberg, J., Carpentier, J. L., and Trono, D. (1999) Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes, Cell 97, 63-73.
10. Piguet, V., and Trono, D. (2001) Living in oblivion: HIV immune evasion, Semin. Immunol. 13, 51-57.
11. Saksela, K. (1997) HIV-1 Nef and host cell protein kinases, Front. Biosci. 2, D606-D618.
12. Quintrell, N., Lebo, R., Varmus, H., Bishop, J. M., Pettenati, M. J., Le Beau, M. M., Diaz, M. O., and Rowley, J. D. (1987) Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hematopoietic cells, Mol. Cell. Biol. 7, 2267-2275.
13. Ziegler, S. F., Marth, J. D., Lewis, D. B., and Perlmutter, R. M. (1987) Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin, Mol. Cell. Biol. 7, 2276-2285.
14. Khati, M., James, W., and Gordon, S. (2001) HIV-macrophage interactions at the cellular and molecular level, Arch. Immunol. Ther. Exp. (Warsz.) 49, 367-378.
15. Martin, J. C., and Bandres, J. C. (1999) Cells of the monocyte-macrophage lineage and pathogenesis of HIV-1 infection, J. Acquir. Immune Defic. Syndr. 22, 413-429.
16. Lee, C.-H., Leung, B., Lemmon, M. A., Zheng, J., Cowburn, D., Kuriyan, J., and Saksela, K. (1995) A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein, EMBO J. 14, 5006-5015.
17. Lee, C.-H., Saksela, K., Mirza, U. A., Chait, B. T., and Kuriyan, J. (1996) Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain, Cell 85, 931-942.
18. + viruses but not for down-regulation of CD4, EMBO J. 14, 484-491.
19. Grzesiek, S., Bax, A., Clore, G. M., Gronenborn, A. M., Hu, J.-S., Kaufman, J., Palmer, I., Stahl, S. J., and Wingfield, P. T. (1996) The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase, Nat. Struct. Biol. 3, 340-345.
20. Moarefi, I., LaFevre-Bernt, M., Sicheri, F., Huse, M., Lee, C.-H., Kuriyan, J., and Miller, W. T. (1997) Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement, Nature 385, 650-653.
21. Briggs, S. D., Sharkey, M., Stevenson, M., and Smithgall, T. E. (1997) SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1, J. Biol Chem. 272, 17899-17902.
22. Lerner, E. C., and Smithgall, T. E. (2002) SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo, Nat. Struct. Biol. 9, 365-369.
23. Hanna, Z., Weng, X., Kay, D. G., Poudrier, J., Lowell, C., and Jolicoeur, P. (2001) The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck, J. Virol. 75, 9378-9392.
24. Schindler, T., Sicheri, F., Pico, A., Gazit, A., Levitzki, A., and Kuriyan, J. (1999) Crystal structure of Hck in complex with a Src family selective tyrosine kinase inhibitor, Mol. Cell 3, 639-648.
25. Sicheri, P., Moarefi, I., and Kuriyan, J. (1997) Crystal structure of the Src family tyrosine kinase Hck, Nature 385, 602-609.
26. Sicheri, F., and Kuriyan, J. (1997) Structures of Src-family tyrosine kinases, Curr. Opin. Struct. Biol. 7, 777-785.
27. c-src, Nature 351, 69-72.
28. LaFevre-Bernt, M., Sicheri, F., Pico, A., Porter, M., Kuriyan, J., and Miller, W. T. (1998) Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue, J. Biol. Chem. 273, 32129-32134.
29. Arold, S., Hoh, F., Domergue, S., Birck, C., Delsuc, M. A., Jullien, M., and Dumas, C. (2000) Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein, Protein Sci. 9, 1137-1148.
30. Arold, S., Franken, P., Strub, M. P., Hoh, F., Benichou, S., Benarous, R., and Dumas, C. (1997) The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling, Structure 5, 1361-1372.
31. Hu, C. D., Chinenov, Y., and Kerppola, T. K. (2002) Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation, Mol. Cell 9, 789-798.
32. Hu, C. D., and Kerppola, T. K. (2003) Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis, Nat. Biotechnol. 21, 539-545.
33. Feil, R., Brocard, J., Mascrez, B., LeMeur, M., Metzger, D., and Chambon, P. (1996) Ligand-activated site-specific recombination in mice, Proc. Natl. Acad. Sci. U.S.A. 93, 10887-10890.
34. Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., and Evan, G. I. (1995) A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins, Nucleic Acids Res. 23, 1686-1690.
35. Muller, A. J., Young, J. C., Pendergast, A. M., Pondel, M., Landau, R. N., Littman, D. R., and Witte, O. N. (1991) BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias, Mol. Cell. Biol. 11, 1785-1792.
36. Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection, Proc. Natl. Acad. Sci. U.S.A. 90, 8392-8396.
37. Briggs, S. D., and Smithgall, T. E. (1999) SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in rat-2 fibroblasts, J. Biol. Chem. 274, 26579-26583.
38. Briggs, S. D., Lerner, E. C., and Smithgall, T. E. (2000) Affinity of Src family kinase SH3 domains for HIV Nef in vitro does not predict kinase activation by Nef in vivo, Biochemistry 39, 489-495.
39. Bahnson, A. B., Dunigan, J. T., Baysal, B. E., Mohney, T., Atchison, R. W., Nimgaonkar, M. T., Ball, E. D., and Barranger, J. A. (1995) Centrifugal enhancement of retroviral mediated gene transfer, J. Virol. Methods 54, 131-143.
40. Wilson, M. B., Schreiner, S. J., Choi, H.-J., Kamens, J. S., and Smithgall, T. E. (2002) Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis, Oncogene 21, 8075-8088.
41. Kienzle, N., Freund, J., Kalbitzer, H. R., and Mueller-Lantzch, N. (1993) Oligomerization of the Nef protein from human immunodeficiency virus (HIV) type 1, Eur. J. Biochem. 214, 451-457.
42. Fujii, Y., Otake, K., Fujita, Y., Yamamoto, N., Nagai, Y., Tashiro, M., and Adachi, A. (1996) Clustered localization of oligomeric Nef protein of human immunodeficiency virus type 1 on the cell surface, FEBS Lett. 395, 257-261.
43. Wang, J. K., Kiyokawa, E., Verdin, E., and Trono, D. (2000) The Nef protein of HIV-1 associates with rafts and primes T cells for activation, Proc. Natl. Acad. Sci. U. S. A 97, 394-399.
44. Robbins, S. M., Quintrell, N. A., and Bishop, J. M. (1995) Myristoylation and differential palmitoylation of the HCK protein-tyrosine kinases govern their attachment to membranes and association with caveolae, Mol. Cell. Biol. 15, 3507-3515.
45. Carreno, S., Gouze, M. E., Schaak, S., Emorine, L. J., and Maridonneau-Parini, I. (2000) Lack of palmitoylation redirects p59Hck from the plasma membrane to p61Hck-positive lysosomes, J. Biol. Chem. 275, 36223-36229.
46. Doms, R. W., and Trono, D. (2000) The plasma membrane as a combat zone in the HIV battlefield, Genes Dev. 14, 2677-2688.
47. Briggs, S. D., Scholtz, B., Jacque, J. M., Swingler, S., Stevenson, M., and Smithgall, T. E. (2001) HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway, J. Biol. Chem. 276, 25605-25611.
48. Komuro, I., Yokota, Y., Yasuda, S., Iwamoto, A., and Kagawa, K. S. (2003) CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPbeta represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection, J. Exp. Med. 198, 443-453.
49. Liu, L. X., Heveker, N., Fackler, O. T., Arold, S., Le Gall, S., Janvier, K., Peterlin, B. M., Dumas, C., Schwartz, O., Benichou, S., and Benarous, R. (2000) Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions, J. Virol. 74, 5310-5319.
50. Grotzinger, J. (2002) Molecular mechanisms of cytokine receptor activation, Biochim. Biophys. Acta 1592, 215-223.
51. Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases, Cell 103, 211-225.
52. Parsons, J. T., and Parsons, S. J. (1997) Src family protein tyrosine kinases: Cooperating with growth factor and adhesion signaling pathways, Curr. Opin. Cell Biol. 9, 187-192.
53. Walk, S. F., Alexander, M., Maier, B., Hammarskjold, M. L., Rekosh, D. M., and Ravichandran, K. S. (2001) Design and use of an inducibly activated human immunodeficiency virus type 1 Nef to study immune modulation, J. Virol. 75, 834-843.
54. Huse, M., and Kuriyan, J. (2002) The conformational plasticity of protein kinases, Cell 109, 275-282.